Cite

HARVARD Citation

    Bayon, B. et al. (n.d.). P1‐066: TREATMENT WITH SP1 INHIBITING DRUGS MODULATES APP AND BACE1 LEVELS IN HUMAN CELLS: IMPLICATION IN TESTING A NOVEL TARGET FOR ALZHEIMER'S DISEASE. Alzheimer's & dementia. p. P327. [Online]. 
  
Back to record